Insulin glargine compared with premixed insulin for management of insulin-naïve type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the open-label, randomized GALAPAGOS study.

@article{Aschner2015InsulinGC,
  title={Insulin glargine compared with premixed insulin for management of insulin-na{\"i}ve type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the open-label, randomized GALAPAGOS study.},
  author={Pablo Aschner and Bipin Kumar Sethi and Fernando Gomez-Peralta and Wolfgang Landgraf and Virginie Loizeau and M P Dain and Val{\'e}rie Pilorget and Abdurrahman Comlekçi},
  journal={Journal of diabetes and its complications},
  year={2015},
  volume={29 6},
  pages={838-45}
}
AIMS Demonstrate superiority of insulin glargine (±glulisine) strategy versus premixed insulin strategy for percentage of patients reaching HbA1c <7% (<53 mmol/mol) at study end without any documented symptomatic hypoglycemia (bloof glucose [BG] ≤3.1 mmol/L) in type 2 diabetes (T2DM) patients failing oral agents. METHODS This 24-week, open-label, multinational trial randomized patients to glargine OD or premix OD or BID, continuing metformin ± insulin secretagogue (IS). Second premix… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 15 references

Similar Papers

Loading similar papers…